​

Taysha Gene Therapies (TSHA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Taysha Gene Therapies Revenue Highlights

Latest Revenue (Y)

$9.77M

0

Taysha Gene Therapies Revenue by Period

Taysha Gene Therapies Revenue by Year

DateRevenueChange
2025-12-31$9.77M17.28%
2024-12-31$8.33M-46.07%
2023-12-31$15.45M517.55%
2022-12-31$2.50M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Taysha Gene Therapies generated $9.77M in revenue during NA 2025, up 17.28% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Taysha Gene Therapies Revenue by Quarter

DateRevenueChange
2026-06-30-100.00%
2026-03-31--100.00%
2025-12-31$5.49M100.00%
2025-09-30--100.00%
2025-06-30$1.99M-13.73%
2025-03-31$2.30M13.85%
2024-12-31$2.02M13.09%
2024-09-30$1.79M60.79%
2024-06-30$1.11M-67.40%
2024-03-31$3.41M-5.36%
2023-12-31$3.60M-24.06%
2023-09-30$4.75M98.16%
2023-06-30$2.40M-49.11%
2023-03-31$4.71M88.09%
2022-12-31$2.50M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--

Taysha Gene Therapies generated - in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Taysha Gene Therapies Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$2.20B$401.25M
RGNXREGENXBIO$170.44M$108.02M
VYGRVoyager Therapeutics$40.37M$3.17M
TSHATaysha Gene Therapies$9.77M-
ABEOAbeona Therapeutics$5.82M$11.38M
NGNENeurogene--
FDMT4D Molecular Therapeutics--
RCKTRocket Pharmaceuticals--
BNTCBenitec Biopharma--
PASGPassage Bio--

TSHA Revenue FAQ

What is Taysha Gene Therapies’s yearly revenue?

Taysha Gene Therapies's yearly revenue for 2025 was $9.77M, representing an increase of 17.28% compared to 2024. The company's yearly revenue for 2024 was $8.33M, representing a decrease of -46.07% compared to 2023. TSHA's yearly revenue for 2023 was $15.45M, representing an increase of 517.55% compared to 2022.

What is Taysha Gene Therapies’s quarterly revenue?

Taysha Gene Therapies's quarterly revenue for Q2 2026 was $0, a 100.00% increase from the previous quarter (Q1 2026), and a -100.00% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a -100.00% decrease year-over-year (Q1 2025). TSHA's quarterly revenue for Q4 2025 was $5.48M, a 100.00% increase from the previous quarter (Q3 2025), and a 171.27% increase year-over-year (Q4 2024).

What is Taysha Gene Therapies’s revenue growth rate?

Taysha Gene Therapies's revenue growth rate for the last 3 years (2023-2025) was -36.75%, and for the last 5 years (2021-2025) was 0%.